Insider Shareholders with Direct Ownership of Cyteir Therapeutics, Inc. (CYT)
This section provides a comprehensive overview of the insiders with direct ownership of Cyteir Therapeutics, Inc. (CYT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cyteir Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Invest Ii Sc Sp Droia
> 10% Shareholder |
3,536,803 | 0 | 3,536,803 $10.6 Million | 1 |
Jun 22, 2021
Added 7.28%
|
|
Novo Holdings
> 10% Shareholder |
4,840,413 | 1,318,277 | 3,522,136 $10.6 Million | 19 |
Jul 20, 2023
Reduced 2.76%
|
|
Markus Md Renschler
President and CEO |
256,707 | 0 | 1,103,661 $3.32 Million | 5 |
Mar 04, 2024
Added 0.57%
|
|
Timothy Romberger
Director |
79,060 | 0 | 369,448 $1.11 Million | 1 |
Jun 22, 2021
Added 17.63%
|
|
Joseph S Zakrzewski
Director |
91,501 | 0 | 227,439 $684,591 | 10 |
Feb 06, 2024
Added 5.86%
|
|
David G Gaiero
Chief Financial Officer |
97,391 | 0 | 102,391 $308,196 | 6 |
Mar 04, 2024
Added 2.27%
|
|
John F Thero
Director |
22,828 | 0 | 22,828 $68,712 | 2 |
Feb 08, 2024
Added 35.98%
|
|
Jean George
Director |
14,150 | 0 | 14,150 $42,591 | 1 |
Feb 14, 2024
Added 50.0%
|
|
Stephen H. Sands
Director |
12,129 | 0 | 12,129 $36,508 | 1 |
Feb 09, 2024
Added 50.0%
|